PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31

PepGen Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$2.70+0.10 (+3.85%)

Close on Oct 19, 2026

Market cap: $186.85M
P/E (TTM): –
Dividend yield: –

PepGen Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31
Cash & Equivalents	23	42	61	143	35	44	49	42	66	134	81	130	147	165	182	196	219	119	133	142	16	6.67	–
Short-Term Investments	94	90	88	21	40	54	71	97	95	41	30	–	–	–	0	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	117	132	149	164	75	98	120	139	161	175	110	130	147	165	182	196	219	119	133	142	16	6.67	–
Prepaid Expenses & Other	3.09	1.97	2.51	2.54	2.83	3.27	3.57	3.51	3.47	2.40	2.27	3.55	3.35	3.07	4.33	4.58	3.43	2.24	2.35	–	–	–	–
Total Current Assets	120	134	151	166	77	101	124	142	165	178	113	133	150	168	186	204	226	126	140	–	–	–	–
Property, Plant & Equipment	1.34	1.57	1.90	2.22	2.49	3.51	3.72	3.90	4.24	4.44	4.76	5.04	5.25	5.34	3.34	2.74	2.84	2.57	0.64	–	–	–	–
Gross Property, Plant & Equipment	5.82	5.79	5.81	5.80	5.72	6.93	6.76	6.59	6.55	6.38	6.34	6.26	6.12	5.88	3.72	2.99	3.26	3.04	1.07	–	–	–	–
Accumulated Depreciation	-4.48	-4.23	-3.91	-3.58	-3.24	-3.43	-3.05	-2.69	-2.31	-1.94	-1.57	-1.22	-0.87	-0.54	-0.39	-0.25	-0.42	-0.47	-0.43	–	–	–	–
Operating Lease Right-of-Use Assets	18	19	19	20	20	21	21	22	23	23	24	24	25	26	27	–	–	–	–	–	–	–	–
Other Long-Term Assets	0.27	0.39	0.37	0.37	0.43	0.43	0.43	0.43	1.96	1.86	0.44	1.99	1.70	1.47	1.47	1.47	1.47	3.64	3.02	–	–	–	–
Total Assets	141	156	174	190	102	127	151	170	194	207	143	164	182	201	217	208	231	132	144	–	–	–	–
Accounts Payable	1.10	0.62	0.82	0.77	0.86	2.70	1.75	5.93	7.74	1.48	1.01	3.99	1.82	1.47	1.36	4.62	5.39	1.89	3.24	–	–	–	–
Accrued Expenses	4.68	5.13	8.64	8.71	12	15	12	7.81	11	6.75	14	14	12	13	12	11	15	14	7.08	–	–	–	–
Current Portion of Leases	3.23	3.21	3.19	3.16	3.14	3.12	3.09	3.07	3.05	3.03	3.00	2.98	3.49	3.66	5.55	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	–	–	–	–	–	–	–	–	3.38	3.34	2.57	3.67	4.00	4.33	–	–	–	–	–
Total Current Liabilities	9.01	8.96	13	13	16	20	17	17	22	11	18	21	17	18	19	16	21	16	10	–	–	–	–
Long-Term Leases	13	13	14	14	15	15	16	16	16	17	17	17	18	18	19	–	–	–	–	–	–	–	–
Operating Lease Liabilities	16	17	17	17	18	18	19	19	19	20	20	20	21	22	25	–	–	–	–	–	–	–	–
Total Liabilities	22	22	26	27	31	36	32	33	38	28	35	38	35	36	38	16	21	16	11	–	–	–	–
Common Stock	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	–	–	–	–	–	–
Additional Paid-In Capital	516	513	509	506	396	393	390	387	383	379	290	288	286	284	283	281	280	2.47	1.65	–	–	–	–
Retained Earnings	-397	-379	-361	-343	-325	-302	-271	-249	-228	-200	-181	-162	-139	-119	-103	-88	-69	-52	-34	–	–	–	–
Comprehensive Income & Other	-0.12	-0.06	0.01	-0.03	-0.04	-0.02	0.02	0.09	-0.08	-0.04	0.03	-0.06	0.01	-0.03	-0.08	-0.13	-0.10	-0.06	0.02	–	–	–	–
Shareholders' Equity	120	134	147	163	71	92	119	137	155	179	108	126	147	165	180	193	210	-50	-32	-26	-18	-13	-6.36
Total Equity	120	134	147	163	71	92	119	137	155	179	108	126	147	165	180	193	210	-50	-32	-26	-18	-13	-6.36
Total Liabilities & Equity	141	156	174	190	102	127	151	170	194	207	143	164	182	201	217	208	231	132	144	–	–	–	–
Shares Outstanding(shares)	–	–	69	–	–	–	33	–	–	–	24	–	–	–	24	–	–	–	0.96	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -67.4%

Financial strength

Current ratio: 13.36
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 252.8%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 1.56
Dividend yield: –